Laura is a Partner in the Economics Consulting practice at AlixPartners and is based in the Boston office. Laura has nearly 30 years of experience in advising private clients and government agencies on competition and regulatory matters in a broad array of sectors, including healthcare and life sciences, technology and communications, consumer products, and professional sports. 

Laura has an established reputation for delivering rigorous economic analyses that combine her strong qualitative and quantitative capabilities to develop in-depth insights for clients. She has led major projects in antitrust litigation, focusing on allegations of monopolization, price fixing, bundling and tying, and exclusionary conduct; and she has evaluated competitive effects, merger efficiencies, and remedy proposals for competition merger reviews. Clients benefit from Laura’s extensive experience in evaluating market definition and market power and estimating consumer harm and damages.

Laura is a member of the American Economic Association, the American Bar Association, and the American Health Lawyers Association.

Key Engagements

  • Led the economics team in the States' antitrust suit challenging Google's Play Store practices. Provided the full spectrum of economic analyses from defining markets through quantifying damages. 
  • On behalf of the US DOJ Antitrust Division, evaluated issues of market definition, market power, and the likely competitive effects of Aon’s proposed acquisition of competing insurance broker WTW.
  • Assessed likely competitive effects of several health plan consolidations; evaluated market definition, competitive effects, likelihood and sufficiency of entry and expansion, merger efficiencies, and monopsony power over providers.
  • In a class action against a major healthcare system, assessed market definition and harm to competition from its use of anti-steering provisions in contracts with health insurers.
  • Assessed damages to a major health data supplier resulting from a competitor’s infringement of patents related to the anonymous linking of patient healthcare data records.
  • Evaluated the overlap of fiber-based telecommunications assets in a proposed merger of business data services firms before the U.S. Department of Justice. 
  • Evaluated allegations of attempted monopolization in several matters against a dominant cell-phone-chip maker.